| Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation R Cappato, FE Marchlinski, SH Hohnloser, GV Naccarelli, J Xiang, ... European heart journal 36 (28), 1805-1811, 2015 | 461 | 2015 |
| Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial M Hendrikx, K Hensen, C Clijsters, H Jongen, R Koninckx, E Bijnens, ... Circulation 114 (1_supplement), I-101-I-107, 2006 | 321 | 2006 |
| Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the QDOT-FAST trial VY Reddy, M Grimaldi, T De Potter, JM Vijgen, A Bulava, ... JACC: Clinical Electrophysiology 5 (7), 778-786, 2019 | 251 | 2019 |
| Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation P Kirchhof, KG Haeusler, B Blank, J De Bono, D Callans, A Elvan, ... European heart journal 39 (32), 2942-2955, 2018 | 241 | 2018 |
| Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first … FG Cosio, E Aliot, GL Botto, H Heidbüchel, CJ Geller, P Kirchhof, ... Europace 10 (1), 21-27, 2008 | 228 | 2008 |
| Performance of handheld electrocardiogram devices to detect atrial fibrillation in a cardiology and geriatric ward setting L Desteghe, Z Raymaekers, M Lutin, J Vijgen, D Dilling-Boer, P Koopman, ... Ep Europace 19 (1), 29-39, 2017 | 201 | 2017 |
| Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF) E Ekanem, VY Reddy, B Schmidt, T Reichlin, K Neven, A Metzner, ... Europace 24 (8), 1256-1266, 2022 | 179 | 2022 |
| Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double … JP Piccini, V Caso, SJ Connolly, KAA Fox, J Oldgren, WS Jones, ... The lancet 399 (10333), 1383-1390, 2022 | 178 | 2022 |
| EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up … H Heidbuchel, G Hindricks, P Broadhurst, L Van Erven, ... European heart journal 36 (3), 158-169, 2015 | 120 | 2015 |
| Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire L Desteghe, L Engelhard, Z Raymaekers, K Kluts, J Vijgen, D Dilling-Boer, ... International journal of cardiology 223, 906-914, 2016 | 102 | 2016 |
| Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators J Vijgen, G Botto, J Camm, CJ Hoijer, W Jung, JY Le Heuzey, A Lubinski, ... Europace 11 (8), 1097-1107, 2009 | 93 | 2009 |
| Occult T wave alternans in long QT syndrome SB Platt, JM Vijgen, P Albrecht, GF Van Hare, MD Carlson, ... Journal of cardiovascular electrophysiology 7 (2), 144-148, 1996 | 93 | 1996 |
| Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF registry MK Turagam, P Neuzil, B Schmidt, T Reichlin, K Neven, A Metzner, ... Circulation 148 (1), 35-46, 2023 | 90 | 2023 |
| A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme M Proietti, GH Mairesse, P Goethals, C Scavee, J Vijgen, I Blankoff, ... Ep Europace 18 (12), 1779-1786, 2016 | 90 | 2016 |
| Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial M Duytschaever, J Vijgen, T De Potter, D Scherr, H Van Herendael, ... EP Europace 22 (11), 1645-1652, 2020 | 88 | 2020 |
| The Belgian improvement study on oral anticoagulation therapy: a randomized clinical trial N Claes, F Buntinx, J Vijgen, J Arnout, J Vermylen, S Fieuws, H Van Loon European heart journal 26 (20), 2159-2165, 2005 | 80 | 2005 |
| Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of … M Duytschaever, T De Potter, M Grimaldi, A Anic, J Vijgen, P Neuzil, ... Circulation: Arrhythmia and Electrophysiology 16 (3), e011780, 2023 | 67 | 2023 |
| A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study RR Tilz, V Schmidt, H Pürerfellner, P Maury, KRJ Chun, M Martinek, ... European heart journal 44 (27), 2458-2469, 2023 | 64 | 2023 |
| Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation L Desteghe, J Vijgen, P Koopman, D Dilling-Boer, J Schurmans, ... European heart journal 39 (16), 1394-1403, 2018 | 61 | 2018 |
| Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: a report from the EURObservational research programme pilot survey on atrial fibrillation … M Proietti, C Laroche, M Drozd, J Vijgen, DC Cozma, J Drozdz, ... American Heart Journal 181, 83-91, 2016 | 54 | 2016 |
